Aceragen logo

Aceragen

Aceragen is a rare disease company striving to restore a better life for patients and families.

2 employees · est. 2021 · Durham, United States

VS
CANbridge Pharmaceuticals Inc.  logo

CANbridge Pharmaceuticals Inc.

To be a global biopharmaceutical company delivering life-changing therapeutics built upon a foundation in China.

63 employees · est. 2012 · Burlington, United States

CANbridge Pharmaceuticals Inc. is the older company (2021 vs 2012); CANbridge Pharmaceuticals Inc. is the larger of the two.

Side-by-Side Comparison

Aceragen CANbridge Pharmaceuticals Inc.
Founded
2021 2012 older
Headquarters
Durham, United States Burlington, United States
Employees
2 63 larger
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology, Health Care, Pharmaceutical
Funding Stage
Private Equity Series E
Total Funding
$35.00M $224.10M
Funding Rounds
1 6
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Rare Diseases, Orphan Diseases, Biopharmaceutical, Therapeutic Treatments, Drug Development, Patient-centric, Community Awareness, Regulatory Outreach, Novel Therapies, Patient Advocacy Biopharmaceutical Company, China, Healthcare Products, Orphan Diseases, Cancer Treatment, Genetic Diseases, Enzyme Replacement Therapy, Oncology, Proprietary Therapeutics, WuXi Biologics, Hunterase, GC Pharma, Puma Biotechnology, NERLYNX, Global Partnership
Website
aceragen.com canbridgepharma.com
Aceragen logo

About Aceragen

Aceragen is a rare disease biopharmaceutical company founded in 2021 with a clear mission to address rare, orphan diseases with no available treatment. Their slogan, "Aceragen is a rare disease company striving to restore a better life for patients and families," reflects their commitment to improvi...

CANbridge Pharmaceuticals Inc.  logo

About CANbridge Pharmaceuticals Inc.

CANbridge Pharmaceuticals Inc. is a China-focused biopharmaceutical company established in 2012 with its headquarters in the United States. The company's slogan is "To be a global biopharmaceutical company delivering life-changing therapeutics built upon a foundation in China." CANbridge is dedicate...

We will tell you when either one moves

BounceWatch watches Aceragen and CANbridge Pharmaceuticals Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Aceragen and CANbridge Pharmaceutic... — by email.

Frequently Asked Questions

Aceragen — Aceragen is a rare disease company striving to restore a better life for patients and families.. CANbridge Pharmaceuticals Inc. — To be a global biopharmaceutical company delivering life-changing therapeutics built upon a foundation in China.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Aceragen has raised $35.00M while CANbridge Pharmaceuticals Inc. has raised $224.10M.
Aceragen and CANbridge Pharmaceuticals Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Aceragen with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Aceragen on 12 Sep 2024, and CANbridge Pharmaceuticals Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes